Amarin focused on CV disease to pump new life into company
This article was originally published in Scrip
Executive Summary
The fundraising that saved Amarin from financial woes last years appear to have given the company a new lease of life. Its interim CEO Dr Declan Doogan told Scrip of his confidence for the company's future.